Emergent BioSolutions (EBS) PT Lowered to $50 at Cantor Fitzgerald, Following Earnings
Tweet Send to a Friend
Cantor Fitzgerald analyst Brandon Folkes lowered the price target on Emergent BioSolutions (NYSE: EBS) to $50.00 (from $95.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
